Milk thistle (Silybum marianum) for the therapy of liver disease

被引:628
作者
Flora, K [1 ]
Hahn, M [1 ]
Rosen, H [1 ]
Benner, K [1 ]
机构
[1] Oregon Hlth & Sci Univ, Div Gastroenterol, Portland, OR 97201 USA
关键词
D O I
10.1111/j.1572-0241.1998.00139.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Silymarin, derived from the milk thistle plant, Silybum marianum, has been used for centuries as a natural remedy for diseases of the liver and biliary tract. As interest in alternative therapy has emerged in the United States, gastroenterologists have encountered increasing numbers of patients taking silymarin with little understanding of its purported properties. Silymarin and its active constituent, silybin, have been reported to work as antioxidants scavenging free radicals and inhibiting lipid peroxidation. Studies also suggest that they protect against genomic injury, increase hepatocyte protein synthesis, decrease the activity of tumor promoters, stabilize mast cells, chelate iron, and slow calcium metabolism. In this article we review silymarin's history, pharmacology, and properties, and the clinical trials pertaining to patients with acute and chronic liver disease. (C) 1998 by Am. Cell. of Gastroenterology).
引用
收藏
页码:139 / 143
页数:5
相关论文
共 51 条
[1]
INHIBITORY EFFECT OF SILYMARIN, AN ANTIHEPATOTOXIC FLAVONOID, ORE 12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED EPIDERMAL ORNITHINE DECARBOXYLASE ACTIVITY AND MESSENGER-RNA IN SENCAR MICE [J].
AGARWAL, R ;
KATIYAR, SK ;
LUNDGREN, DW ;
MUKHTAR, H .
CARCINOGENESIS, 1994, 15 (06) :1099-1103
[2]
ALBRECHT M, 1992, Z KLIN MED, V47, P87
[3]
PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].
BARZAGHI, N ;
CREMA, F ;
GATTI, G ;
PIFFERI, G ;
PERUCCA, E .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338
[4]
BOARI C, 1981, DRUG EXP CLIN RES, V7, P115
[5]
EFFECT OF THE FLAVANOLIGNANS OF SILYBUM-MARIANUM L ON LIPID-PEROXIDATION IN RAT-LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES [J].
BOSISIO, E ;
BENELLI, C ;
PIROLA, O .
PHARMACOLOGICAL RESEARCH, 1992, 25 (02) :147-154
[6]
BREVOORT P, 1996, HERBALGRAM, V36, P49
[7]
BUELLES H, 1971, ARZNEIMITTEL-FORSCH, V21, P1206
[8]
LIPID-PEROXIDATION AND IRREVERSIBLE DAMAGE IN THE RAT HEPATOCYTE MODEL - PROTECTION BY THE SILYBIN PHOSPHOLIPID COMPLEX IDB-1016 [J].
CARINI, R ;
COMOGLIO, A ;
ALBANO, E ;
POLI, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (10) :2111-2115
[9]
CAVALIERI S, 1974, GAZZ MED ITAL, V133, P628
[10]
COWLEY G, 1996, NEWSWEEK 0603, P60